Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer
Crossref DOI link: https://doi.org/10.1038/s41598-018-32881-6
Published Online: 2018-10-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Hai-Yuan
Ma, Ding
Liu, Yi-Rong
Hu, Xin
Zhang, Jian
Wang, Zhong-Hua
Di, Gen-Hong
Hu, Xi-Chun
Shao, Zhi-Ming
Text and Data Mining valid from 2018-10-12
Version of Record valid from 2018-10-12
Article History
First Online: 12 October 2018